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cuts in drug prices. The introduction of the policies will be
phased in up until 2011. METHODS: This study examines the
initiatives and estimates the savings that each will provide. It also
examines the basis for the claimed long-term ﬁscal crisis. The
analysis builds on earlier work presented at the 11th annual
ISPOR conference in Philadelphia. Planned policy initiatives
include mandatory price cuts for off-patent medicines and the
adjustment of reimbursed prices to reﬂect manufacturer dis-
counting. RESULTS: The estimated impact of the range of cost
cutting measures should see pharmaceutical expenditures grow
at less than 5% per annum over the next 5 years. The new poli-
cies will cut over A$2billion from Government expenditure. 
The underlying growth rate for pharmaceuticals expenditure,
without any cost cutting initiatives, is estimated at 5% from the
increase in volumes and 4% from growth in the average cost per
unit sold. The “intergenerational report” is based on a number
of ﬂawed assumptions and has been used as justiﬁcation for
cutting health expenditures. In the same period defence expen-
ditures have grown rapidly. CONCLUSION: The policy initia-
tives will cut deeply into pharmaceutical spending. These cuts
have been justiﬁed by a spurious case built by Government to
cut health expenditure and to shift funding into newer priority
areas. The public has not been engaged in an open debate around
which priorities they would select.
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OBJECTIVES: Individual’s Health locus of control inﬂuence
health-related behaviors, but their association with health care
utilization is unclear. We aimed to investigate the association
between an individual’s health locus of control and the use of
conventional and alternative health care. METHODS: We con-
ducted prospective cohort study of community-dwelling adults
from the nationally representative random sample of households
in Japan. We measured the health locus of control and symptom-
related visits to physicians and the use of dietary and physical
complementary and alternative medicine (CAM). Dietary CAM
included supplements, such as herbs and vitamins. Physical CAM
included manipulations, such as acupuncture and acupressure.
RESULTS: Of the 3568 subjects who participated in the study,
3477 participants completed the diary. Out of these subjects,
there were 2,453 aged 18 years and older, of which, 2103 (86%;
95% CI, 84–88%) had developed at least one symptom during
the 31-day study period. Of these symptomatic adults, 639
visited physicians (30%; 95% CI, 28–32%), 480 used dietary
CAM (23%; 95% CI, 21–25%) and 156 (7%; 95% CI, 6–9%)
used physical CAM. The likelihood of visiting a physician was
not related signiﬁcantly to an individual’s health locus of control.
However, increased use of dietary CAM was possibly associated
with control by spiritual powers (p = 0.028), internal control (p
= 0.013) and less control by professionals (p = 0.020). Increased
use of physical CAM was signiﬁcantly associated with control
by spiritual powers (p = 0.009). CONCLUSION: The likelihood
of visiting physicians does not differ by the individual’s health
locus of control. Control by spiritual powers is involved with
increased CAM use. Internal control is possibly associated with
greater use of dietary CAM; professional control is possibly 
associated with less use of dietary CAM. 7 modiﬁed by
157.104.15.177 on 1-4-2007.
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OBJECTIVES: To examine potential relationships between
national expenditure and health care indicators across a number
of economically developed countries. METHODS: The World
Health Organisation (WHO) has recently made available a data-
base containing a number of health care, demographic and eco-
nomic indicators from a range of countries. From this database
we have collated data on seven WHO health care indicators, esti-
mated GDP and total health care expenditure (HCE) for 30 eco-
nomically developed countries. The log-transformed values for
GDP and HCE were then correlated with the health care indi-
cators to determine their level of association. RESULTS: We ﬁnd
that all of the health care indicators are signiﬁcantly correlated
with both GDP and HCE (P < 0.05). GDP is more strongly cor-
related than HCE with infant mortality rates, maternal mortal-
ity ratios, neonatal mortality rates and the probability of dying
under ﬁve years of age. HCE is more strongly correlated than
GDP with healthy life expectancy (HALE) at birth, average life
expectancy at birth and the probability of dying between ages
15 and 60 years old. The strongest correlation is between HALE
and HCE, where r = 0.83 (P < 0.001). Outliers in this correla-
tion are Japan, Spain and Sweden, which have a higher than
expected HALE, and the USA and Hungary which have a lower
than expected HALE. CONCLUSION: In general there is a high
level of association between economic and health care indicators
in economically developed countries. In particular there is a
strong correlation between total health care expenditure and
healthy life expectancy. This does not necessarily imply a causal
relationship, as there are many other factors that may inﬂuence
health care indicators. However, further analysis of these rela-
tionships may provide insight into differences in life expectancy,
and the effectiveness of different national health care systems.
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OBJECTIVES:—Characterize dynamics of drug use in EU15
countries, with focus on CZ.—Deﬁne tools used to slow down
unreasonable increase in drug expenditures. METHODS: Liter-
ature search on cost containment, EU prices, regulation of drug
expenditures and drug policy in CZ. RESULTS: Regulation tools
in EU countries used for drug expenditures are legislative or
administrative, issued by executive institutions. Dynamics of
expenditures increase is measured by % of GDP allocated for
drugs, health care, and reimbursement level. Regulation is
focused on drug demand and supply, precautions in drug policy,
control of drug prices, co-payment by patient. Regulation
systems are country speciﬁc. Reforms provided in the ﬁeld of
drug reimbursement from public aid showed that partial pre-
cautions focused on producers, drug distributors, care providers
or patients have short term effect only. More effective are pre-
cautions of complex character, which affect behavior of produc-
ers, distributors, care providers and inhabitants on drug market.
Signiﬁcant instrument for effective drug policy is process of nego-
tiation between the actors on drug market and process of 
systematic explanation of taken precautions in relation to 
